Recipharm Advanced Bio

Stockholm, Sweden
Find alternatives to Recipharm Advanced Bio for AAV →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (11) ○ EMA GMP ○ MHRA GMP

Quick Facts: Recipharm Advanced Bio

Signal Score
63.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Stockholm, Sweden
Modalities
AAV, Lentiviral, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Recipharm Advanced Bio

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: Recipharm
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Recipharm
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Stockholm, SE
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100
Sites: Stockholm, SE
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals11 articles (not scored)
1 manufacturing site: Stockholm, SE
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (36 postings on Nov 20, 2026), and we can't yet tell which of those roles belong to it. Why: the Recipharm Personio board covers Wasserburg only, none of the Advanced Bio sites. We'd rather show no number than one that isn't really this company's.
Source: personio · Checked Nov 20, 2026

Company Signals 11 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-03-23
Recipharm shutters Boxborough facility, cuts local workforce 40% - Worcester Business Journal
Recipharm shutters Boxborough facility, cuts local workforce 40%  Worcester Business Journal
news Wed, 22 No
Change at the top at Recipharm as strategy shifts - pharmaphorum
news Wed, 18 Fe
Recipharm focuses footprint with sale of Israel API plant, new CDMO partnership - Fierce Pharma
news Wed, 01 Ap
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - PR Newswire
news Tue, 17 Fe
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm - PR Newswire
news Tue, 16 Ju
Recipharm makes major investment to expand US sterile manufacturing footprint - European Pharmaceutical Review
news Tue, 16 Ju
Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand - Fierce Pharma
news Tue, 01 Oc
Recipharm and Exela Pharma Sciences Form Exclusive CDMO Strategic Alliance - Genetic Engineering and Biotechnology News
news Thu, 13 Fe
Recipharm bolsters fill/finish capacity at German site - BioProcess International
news Thu, 11 Se
LGC opens $72M chemical plant; Recipharm partners with NeuroSense - Endpoints News
news Mon, 26 Ja
Responding to tougher FDA standards, Recipharm debuts new facility for beta-lactam drugs - Fierce Pharma

Frequently Asked Questions About Recipharm Advanced Bio

What is Recipharm Advanced Bio's CDMO Signal Score?
Recipharm Advanced Bio has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Recipharm Advanced Bio for a manufacturing program?
Use the free AI matchmaker to compare Recipharm Advanced Bio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
NecstGen
Leiden, NL
Signal Score: 78.1
AAV, Lentiviral, Cell Therapy
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose

Compare Recipharm Advanced Bio with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Recipharm Advanced Bio
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.